During the past decade, a plethora of biomarkers have been reported to be associated with incident cardiovascular disease, often in large meta-analyses. A new review of these meta-analyses suggests that many of these studies are subject to substantial bias; therefore, how should we interpret the results, and where do we go from here?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vasan, R. S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113, 2335–2362 (2006).
Tzoulaki, I., Siontis, K. C., Evangelou, E. & Ioannidis, J. P. Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern. Med. 173, 664–671 (2013).
Wang, T. J. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 123, 551–565 (2011).
Ioannidis, J. P. & Tzoulaki, I. Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. Circ. Res. 110, 658–662 (2012).
Ioannidis, J. P., Patsopoulos, N. A. & Evangelou, E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335, 914–916 (2007).
Sterne, J. A., Gavaghan, D. & Egger, M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J. Clin. Epidemiol. 53, 1119–1129 (2000).
Greenland, P. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122, e584–e636 (2010).
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G & PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009).
Riley, R. D., Lambert, P. C. & Abo-Zaid, G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340, c221 (2010).
Nissen, S. E. Biomarkers in cardiovascular medicine: the shame of publication bias: comment on “bias in associations of emerging biomarkers with cardiovascular disease”. JAMA Intern. Med. 173, 671–672 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tsao, C., Vasan, R. Biomarkers of cardiovascular outcomes—bonanza or bias?. Nat Rev Endocrinol 9, 381–382 (2013). https://doi.org/10.1038/nrendo.2013.99
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2013.99